- Home
- TCRX vs EEA Comparison
TCRX vs EEA Comparison
Compare TCRX & EEA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TCRX
- EEA
- Stock Information
- Founded
- TCRX 2018
- EEA 1986
- Country
- TCRX United States
- EEA Germany
- Employees
- TCRX N/A
- EEA N/A
- Industry
- TCRX Biotechnology: Pharmaceutical Preparations
- EEA Trusts Except Educational Religious and Charitable
- Sector
- TCRX Health Care
- EEA Finance
- Exchange
- TCRX Nasdaq
- EEA Nasdaq
- Market Cap
- TCRX 67.9M
- EEA 57.7M
- IPO Year
- TCRX 2021
- EEA N/A
- Fundamental
- Price
- TCRX $1.44
- EEA $9.06
- Analyst Decision
- TCRX Strong Buy
- EEA
- Analyst Count
- TCRX 6
- EEA 0
- Target Price
- TCRX $9.83
- EEA N/A
- AVG Volume (30 Days)
- TCRX 520.8K
- EEA 9.2K
- Earning Date
- TCRX 05-12-2025
- EEA 01-01-0001
- Dividend Yield
- TCRX N/A
- EEA 1.92%
- EPS Growth
- TCRX N/A
- EEA N/A
- EPS
- TCRX N/A
- EEA N/A
- Revenue
- TCRX $2,816,000.00
- EEA N/A
- Revenue This Year
- TCRX $47.30
- EEA N/A
- Revenue Next Year
- TCRX $74.30
- EEA N/A
- P/E Ratio
- TCRX N/A
- EEA N/A
- Revenue Growth
- TCRX N/A
- EEA N/A
- 52 Week Low
- TCRX $1.02
- EEA $7.45
- 52 Week High
- TCRX $9.69
- EEA $9.26
- Technical
- Relative Strength Index (RSI)
- TCRX 49.74
- EEA 54.76
- Support Level
- TCRX $1.02
- EEA $8.11
- Resistance Level
- TCRX $1.36
- EEA $9.28
- Average True Range (ATR)
- TCRX 0.16
- EEA 0.20
- MACD
- TCRX 0.05
- EEA 0.03
- Stochastic Oscillator
- TCRX 77.78
- EEA 89.62
About TCRX TScan Therapeutics Inc.
TScan Therapeutics Inc is a biopharmaceutical company focused on the development of T-cell receptor (TCR) engineered T cell therapies (TCR-T) for the treatment of patients with cancer. The company's liquid tumor TCR-T therapy candidates, TSC-100 and TSC-101, are in development for the treatment of patients with hematologic malignancies to eliminate residual leukemia and prevent relapse after hematopoietic stem cell transplantation. It is also developing multiplexed TCR-T therapy candidates for the treatment of various solid tumors.
About EEA The European Equity Fund Inc.
European Equity Fund, Inc / MD is a United States-based diversified, closed-end management investment company. The fund seeks long-term capital appreciation through investment in equity and equity securities of issuers domiciled in Europe. Its portfolio of investments consists of different sectors such as industrials, financials, healthcare, consumer discretionary, materials, consumer staples, information technology, and other sectors.